ADAMTS1 and renal cell carcinoma: To elucidate the clinical relevance of ADAMTS1 in patients with RCC, we initially analyzed its expression levels in 277 noncancerous tissues and 566 RCC samples obtained from gene chip data provided by the TNMplot database.